Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XIFR
1701
XPLR Infrastructure LP
XIFR
$1.08B
| $4.39M | ﹤0.01% |
62,643
+48,066
| +330% | +$3.6M |
|
1702
GoPro
GPRO
$126M
| $4.39M | ﹤0.01% |
881,489
+153,078
| +21% | +$803K |
|
1703
Champion Homes
SKY
$5.14B
| $4.38M | ﹤0.01% |
84,966
+46,731
| +122% | +$2.49M |
|
1704
Synaptics
SYNA
$4.15B
| $4.38M | ﹤0.01% |
45,988
-21,091
| -31% | -$2.03M |
|
1705
Twist Bioscience
TWST
$7.25B
| $4.37M | ﹤0.01% |
183,517
+74,344
| +68% | +$2.16M |
|
1706
ProShares UltraPro QQQ
TQQQ
$37.9B
| $4.37M | ﹤0.01% |
504,728
+503,728
| +50,373% | +$5.11M |
|
1707
CALL
General Mills
GIS
$19.7B
| $4.36M | ﹤0.01% |
+52,000
| New | +$4.24M |
|
1708
PUT
NetEase
NTES
$84.7B
| $4.36M | ﹤0.01% |
+60,000
| New | +$4.08M |
|
1709
Enovix
ENVX
$1.03B
| $4.36M | ﹤0.01% |
400,294
+22,475
| +6% | +$277K |
|
|
JJE
1710
DELISTED
iPath Series B Bloomberg Energy Subindex Total ReturnSM ETN
JJE
| $4.35M | ﹤0.01% |
80,000
| – | – |
|
|
PDM
1711
Piedmont Realty Trust
PDM
$1.19B
| $4.35M | ﹤0.01% |
474,459
-40,657
| -8% | -$402K |
|
1712
The Ensign Group
ENSG
$10.7B
| $4.35M | ﹤0.01% |
45,940
-6,590
| -13% | -$598K |
|
1713
Lufax Holding
LU
$1.3B
| $4.32M | ﹤0.01% |
556,117
+126,859
| +30% | +$966K |
|
1714
ACI Worldwide
ACIW
$5.42B
| $4.3M | ﹤0.01% |
186,882
+30,015
| +19% | +$646K |
|
|
CFIV
1715
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
| $4.29M | ﹤0.01% |
420,235
| – | – |
|
1716
Popular Inc
BPOP
$11.1B
| $4.29M | ﹤0.01% |
64,654
+19,668
| +44% | +$1.37M |
|
1717
CALL
Twilio
TWLO
$36.6B
| $4.27M | ﹤0.01% |
+87,200
| New | +$4.96M |
|
1718
PUT
Aehr Test Systems
AEHR
$3.36B
| $4.26M | ﹤0.01% |
+211,800
| New | +$4.53M |
|
1719
CALL
Cinemark Holdings
CNK
$4.32B
| $4.25M | ﹤0.01% |
+491,100
| New | +$5.53M |
|
1720
PUT
Bloom Energy
BE
$64.6B
| $4.25M | ﹤0.01% |
+222,400
| New | +$4.37M |
|
1721
Associated Banc-Corp
ASB
$5.91B
| $4.25M | ﹤0.01% |
183,915
+69,461
| +61% | +$1.6M |
|
|
SVC
1722
Service Properties Trust
SVC
$1.07B
| $4.23M | ﹤0.01% |
116,081
+11,940
| +11% | +$438K |
|
|
DEA
1723
Easterly Government Properties
DEA
$1.18B
| $4.21M | ﹤0.01% |
118,115
+7,541
| +7% | +$293K |
|
1724
Helmerich & Payne
HP
$3.71B
| $4.21M | ﹤0.01% |
84,940
+40,094
| +89% | +$1.91M |
|
1725
U-Haul Holding Co Series N
UHAL.B
$12.8B
| $4.2M | ﹤0.01% |
+76,412
| New | +$4.42M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.